Aba HO, Whong CMZ, Aminu M (2012). Co-Infection of human immunodeficiency virus and hepatitis B surface Antigen among pregnant women in Kaduna, Nigeria. J. Immunol. 137(1): 185-772.

Adekanle O, Ndububa DA, Ayodeji OO, Paul-Odo B, Folorunso TA (2010). Sexual transmission of the hepatitis B virus among blood donors in a tertiary hospital in Nigeria. Singapore J. Med. 51(12):944-947.

Ahizechukwu CE, Uzoamaka AE, Charles IO, Ifeanyichukwu UE, Chukwuanugo O (2011). Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. J. Virol. 8(1):8-12.

Aminu M, Okachi EE, Sani MA, Abdullateef Y (2013). Prevalence of hepatitis B virus surface antigen among healthy asymptomatic students in Nigerian university. Ann. Afr. J. Med. 12(1): 55-56.
Crossref

Alo MN, Alhassan HM, Saidu AY, Ugah UI, Abdulahi H (2013) Seroprevalence of hepatitis B surface antigen (HBsAg) among the medical students of Usmanu Danfodiyo university, Sokoto, Sokoto State, Nigeria. Europ. J. Exper. Biol. 3(3):666-671.

Ballah AD, Babajide A, Abubakar UA, Abubakar AB, Cecilia A, Ernest E, Mohammed BA (2012). A survey of Hepatitis B and C virus prevalence in human immunodeficiency virus positive patients in a tertiary institution in north eastern Nigeria. Int. J. Med. Med. Sci. 4(1):13-18.

Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M (2009). Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr. Health Sci. 9(2):98-108.
Pubmed

Cheesbrough M (2006). District laboratory practice in tropical countries. USA: Cambridge University, press: 2nd ed. pp. 295-297.
Crossref

Dawaki SS, Kawo AH (2006). Seroprevalence of Hepatitis B Surface Antigen (HBsAg) in pregnant women attending an urban maternity hospital in Kano, Nigeria. Nigeria. J. Microbl. 20: 705-709.

Dienstag JL, Isselbacher KJ (2005). Acute viral hepatitis. In: Hawison`s principles of internal medicine, Kaspar DL, Baunwald E, Frauci AS, Hawer SL, Longo DL, Jameson JL. 6th Ed. vol. II, the Macgraw-Hill companies inc., New York, pp. 1822-1838.

Elgouhari HMTI, Tamimi AR, Carey WD (2008). Hepatitis B virus infection: understanding its epidemiology, cause and diagnosis. Clevel. J. Med. 75(12):881-889.
Crossref

Ejele OA, Nwauche CA, Erhabor O (2004). The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria. Nig. J. Med. 13(2):175-179.
Pubmed

Emechebe GO, Emodi IJ, Ikefuna AN, Ilechukwu GC, Igwe WC, Ejiofor OS, Ilechukwu CA (2009). Hepatitis B virus infection in Nigeria. A review, Nig. Med. J. 50(1):18-22.

Fattovich G (2003). Natural history of hepatitis B. J. Hepatol. 39(1):50-58.
Crossref

Kouassi-M'Bengue A, Boni CC, Ouattara D, Berthé K, Doumbia M, Sévédé D, Saraka D, Méité S, Dosso M (2011). Co-infection of HIV and HBV in voluntary counseling and testing center in Abidjan. Asian Pac. J. Trop. Dis. 1(4):275-278.
Crossref

Mustapha SK, Jibrin YB (2004). The prevalence of Hepatitis B Surface Antigenaemia in patients with Human Immunodeficiency Virus (HIV) infection in Gombe Nigeria. Ann. Afr. Med. 3(1):10-12.

Mboto CI, Edet EJ (2012). Prevalence and risk factors of Hepatitis B Virus infection among students in university of Uyo. Int. J. Mod. Biol. Med. 2(2): 101-111.

Ndako AJ, Obinna ON, Georgebest, ON, Echeonwu, SA, Junaid OA, Tiri JA (2011). Studies on prevalence and risk factors for Hepatitis B Surface Antigen among secondary school students in north-central, Nigeria. Sierra Leone J. Biomed. Res. 3(3):163-168.

Nwokediuko SC (2010). Risk factors for hepatitis B virus transmission in Nigerians: A case-control study. Int. J. Gastroenterol. 10(1):10-11.

Ogoina D, Pondei K, Adetunji B, Chima G, Isichei C, Gidado S (2014). Prevalence of hepatitis B vaccination among health care workers in Nigeria in 2011-2012. Int. J. Occupat. Environ. Med. 5(1):51-56.

Okonko IO, Anugweje KC, Adeniji FO, Abdulyekeen RA (2012). Syphilis and HIV, HCV and HBsAg co-infections among sexually active adults. Nat. Sci. 10(1):66.

Otegbayo JA, Fasola FA, Abja A (2003). Prevalence of hepatitis B surface antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nig. Trop. Gastrol. 24(4):196-197.

Otori MO, Aminu M, Mukhtar HM, Okojokwu OJ (2013). Predominant blood group antigen and risk factors associated with HIV infection among HIV positive patients in Zaria, Kaduna state, Nigeria. Int. J. Pharm. Chem. Biol. Sci. 3(4):1052-1060.

Pauchaud C, Woog V, Singh S, (2002). Issues in measuring HIV prevalence: the case of Nigeria. Afr. J. Reprod. Health, 6(3):11-29.
Crossref

Pennap GR, Nwachukwu O, Ishaleku D, Ombugadu RJ (2011). Hepatitis B virus carriage among student of a Nigerian tertiary institution: A cohort of eligible blood donor. Research J. Med. Sci. 5(2):90-93.

Pido B, Magid K (2005). Prevalence of hepatitis B virus (HBV) infection among Makerere university medical students. Afr. Health Sci. 5(2):93-98
Pubmed

School of Postgraduate Studies Handbook (2011). Postgraduate student's handbook, Ahmadu Bello University, Zaria. ABU press limited, Zaria. pp. 12-13.

Shepard CW, Edgar P, Simard LF, Anthony EF, Beth PB (2006). Hepatitis B virus infection: epidemiology and vaccination. Oxford J. Med. Epideml. Rev. 28(1):112-125.

Ugwuja E, Ugwu N (2009). Seroprevalence of hepatitis B surface antigen and liver tests among adolescents in Abakaliki, south eastern Nigeria. Int. J. Trop. Med. 6(2):50.

Willey JM, Sherwood LM, Woolverton CJ (2011). Prescotts microbiology, (8th Edition). Mcgraw Hills Intern. Ed. Publ. U.S.A. pp. 919-920.

World Health Organization (2010). Prevalence of hepatitis B virus infection in the world by country. http://www.who.int/csr/disease/hepatitis/en/.

World Health Organization (2012). Hepatitis B: Global alert and response.Www.Who.Int.14-03-2012. Center for Disease Control. Hepatitis: Www.Cdc.Gov/Hepatitis/Statistics.Htm